Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication November 18, 2011
- Accepted for publication March 14, 2012
- Published online June 1, 2012.
Article Versions
- previous version (May 10, 2012 - 08:00).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2012 by the Society of Nuclear Medicine, Inc.
Author Information
- Paola A. Erba1,2,
- Martina Sollini1,
- Enrico Orciuolo3,
- Claudio Traino4,
- Mario Petrini3,
- Giovanni Paganelli5,
- Emilio Bombardieri6,
- Chiara Grana5,
- Leonardo Giovannoni7,
- Dario Neri8,
- Hans D. Menssen*,7 and
- Giuliano Mariani*,1
- 1Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa, Italy
- 2Nuclear Medicine Department, Santa Maria Nuova Hospital, IRCCS, Reggio Emilia, Italy
- 3Department of Hematology, University of Pisa Medical School, Pisa, Italy
- 4Health Physics Division, University Hospital of Pisa, Pisa, Italy
- 5Department of Nuclear Medicine, European Institute of Oncology, Milan, Italy
- 6Montabone Unit for New Drug Development and Nuclear Medicine Division, Istituto Nazionale dei Tumori, Milan, Italy
- 7Philogen SpA, Siena, Italy; and
- 8Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland
- For correspondence or reprints contact: Paola A. Erba, Regional Center of Nuclear Medicine, University of Pisa Medical School, Via Roma 67, I-56100 Pisa, Italy. E-mail: p.erba{at}med.unipi.it
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockade
- Targeted Delivery of IL2 to the Tumor Stroma Potentiates the Action of Immune Checkpoint Inhibitors by Preferential Activation of NK and CD8+ T Cells
- Antibody-Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity
- TGF-{beta} induces oncofetal fibronectin that, in turn, modulates TGF-{beta} superfamily signaling in endothelial cells
- Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
- Therapeutic vaccination targeting the tumour vasculature
- Curative Properties of Noninternalizing Antibody-Drug Conjugates Based on Maytansinoids
- Radretumab Radioimmunotherapy in Patients with Brain Metastasis: A 124I-L19SIP Dosimetric PET Study